Heparin-binding growth factor(s) derived from head and neck squamous cell carcinomas induce endothelial cell proliferation

Head and Neck

Volumn 19, Issue 7, 1997, Pages 576-582

  Petruzzelli, Guy J ^a,b   Benefield, Janet ^a,b   Taitz, Ari D ^a   Fowler, Sarah ^a   Kalkanis, James ^c   Scobercea, Sebastian ^d   West, Derrick ^a   Rita I Young, M ^a,b  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^b HINES VA HOSPITAL   (United States)

^c SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d ADVOCATE LUTHERAN GENERAL HOSPITAL   (United States)

Author keywords

Angiogenesis; Head and neck carcinoma; VEGF VPF

Indexed keywords

ACIDIC FIBROBLAST GROWTH FACTOR; BASIC FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR; PROSTAGLANDIN E2; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; CELL PROLIFERATION; HEAD AND NECK CANCER; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN ISOLATION; SQUAMOUS CELL CARCINOMA;

CARCINOMA, SQUAMOUS CELL; CELL DIVISION; CHROMATOGRAPHY, AFFINITY; CYTOKINES; DINOPROSTONE; ENDOTHELIAL GROWTH FACTORS; ENDOTHELIUM; FIBROBLAST GROWTH FACTOR 2; HEAD AND NECK NEOPLASMS; HUMANS; NEOVASCULARIZATION, PATHOLOGIC; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED;

EID: 0030924141     PISSN: 10433074     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0347(199710)19:7<576::AID-HED3>3.0.CO;2-4     Document Type: Article

References (36)

1. Folkman J. The role of angiogenesis in tumor growth. Sem Cancer Biol 1992;3:65-71.
2. Folkman J. Tumor angiogenesis. In: Becker FF, ed. Cancer: a comprehensive treatise. New York: Plenum Press, 1975:355-388.
3. Folkman J, Cotran RS. Relation of vascular proliferation to tumor growth. Int Rev Exp Pathol 1976;16:207-248.
4. Folkman J. Tumor angiogenesis: therapeutic implications. New Engl J Med 1971;85:1182-1186.
5. Folkman J. What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 1990;82:4-6.
6. Greenblat M, Shubil P. Tumor angiogenesis: transfilter diffusion studies in the hamster by transparent chamber techniques. J Natl Cancer Inst 1968;1:111-124.
7. Folkman J, Merler E, Abernathy C, Williams G. Isolation of a tumor factor responsible for angiogenesis. J Exp Med 1971;133:275-288.
8. Petruzzelli GJ. Tumor angiogenesis. Head Neck 1996;18:283-291.
9. Shing Y, Folkman J, Sullivan R, Butterfield C, Murray J, Klagsbrun M. Heparin affinity: purification of a tumor derived capillary endothelial cell growth factor. Science 1984;223:1296-1298.
10. Shing Y, Klagsbrun M, Folkman J. A new method for purifying heparin-binding growth factors. Ann New York Acad Sci 1989;56:166-172.
11. Petruzzelli GJ, Synderman CH, Johnson JT. Angiogenesis induced by head and neck squamous cell carcinoma xeno-grafts in the chick embryo squamous cell carcinoma model. Ann Otol Rhinol Laryngol 1993;102:215-221.
12. Weidner N. Tumor angiogenesis: a review of current applications in tumor prognostication. Sem Diag Pathol 1993;10:302-313.
13. Weidner N, Carroll PR, Flax J, Blumenfeld W, Folkman J. Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am J Pathol 1993;143:401-409.
14. Weidner N, Folkman J, Pozza et al. Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. J Natl Cancer Inst 1992;84:1875-1887.
15. Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis-correlation with invasive breast carcinoma. New Engl J Med 1991;324:1-7.
16. Leek RD, Harris AL, Lewis CE. Cytokine networks in solid human tumors: regulation of angiogenesis. J Leukocyte Biol 1994;56:423-435.
17. Thomas GR, Tubb EE, Sessions RB, Cullen KJ. Growth factor mRNA expression in human head and neck malignant tumors. Arch Otolaryngol Head Neck Surg 1993;119:1247-1252.
18. Grandis JR, Tweardy DJ. The role of peptide growth factors in head and neck carcinoma. Otolaryngol Clin North Am 1992;25:1105-1115.
19. Schultz-Hector S, Haghayegh S. Basic-fibroblast growth factor expression in human and murine squamous cell carcinomas and its relationship to regional endothelial cell proliferation. Cancer Res 1993;53:1444-1449.
20. Yamamoto N, Matsutani S, Yoshitake Y, Nishikawa K. Immunohistochemical localization of basic fibroblast growth factor in A431 human epidermoid carcinoma cells. Histochemistry 1991;96:479-485.
21. Snyderman CH, Milanovich M, Wagner RL, Johnson JT. Prognostic significance of prostaglandin E-2 production in fresh tissues of head and neck cancer patients. Head Neck 1995;17:108-113.
22. Senger DR, Van Der Water L, Brown LF, et al. Vascular permeability factor (VPF, VEGF) in tumor biology. Cancer Metast Rev 1993;12:303-324.
23. Gospodarowicz D, Abraham JA, Schilling J. Isolation and characterization of a newly identified endothelial cell mitogen factor produced by pituitary derived folliculostellate cells. Proc Natl Acad Sei USA 1989;86:7311-7315.
24. Leung W, Cachianes G, Kuang W-J, Goeddel DV, Ferrara N. Vascular endothelial cell growth factor is a secreted angiogenic mitogen. Science 1989;246;1306-1309.
25. Gospodarowicz D. Vascular endothelial cell growth factor. In: Aggarwall BB, Gutterman JU, eds. Human cytokines: handbook for basic and clinical research. Boston: Blackwell Scientific Publications, 1992:353-364.
26. Shibuya M. Role of VEGF-fit receptor system in normal and tumor angiogenesis. Adv Cancer Res 1995;67:281-316.
27. Wilting J, Christ B, Bokeloh M, Weich HA. In vivo effects of vascular endothelial cell growth factor on the chicken chorioallantoic membrane. Cell Tissue Res 1993;274:163-172.
28. Plouet J, Bayard F. Regulations of vasculatropin/vascular endothelial growth factor bioavailability. Horm Res 1994;42:14-19.
29. Dvorak HF, Sioussat TM, Brown LF, et al. Distribution of vascular permeability factor (vascular endothelial cell growth factor) in tumors: concentration in tumor blood vessels. J Exp Med 1991;174:1275-1278.
30. Expression of vascular permeability factor/vascular endothelial growth factor by melanoma increases tumor growth, angiogenesis, and experimental metastasis. Cancer Res 1996;56:172-181.
31. Guidi AJ, Abu-Jawdeh, Berse B, et al. Vascular permeability factor (vascular endothelial cell growth factor) expression and angiogenesis in cervical neoplasia. J Natl Cancer Inst 1995;87:1237-1245.
32. Guidi AJ, Abu-Jawdeh, Berse B, et al. Expression of vascular permeability factor (vascular endothelial cell growth factor) and its receptor in endometrial carcinoma. Cancer 1996;78:454-460.
33. Maeda K, Chung Y, Ogawa Y, et al. Prognostic value of vascular endothelial growth factor expression in gastric carcinoma. Cancer 1996;77:858-863.
34. Roberts AB, Sporn MB. Transforming growth factor-B. In: Aggarwall BB, Gutterman JU, eds. Human cytokines: handbook for basic and clinical research. Boston: Blackwell Scientific Publications, 1992:399-417.
35. Kim KJ, Li B, Winer J, et al. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumor growth in vivo. Nature 1993;362:841-844.
36. 121. Cancer Res 1995;55:5296-5301.